From the Journals

Seven days of opioids adequate for most hernia and other general surgery procedures


 

FROM JAMA SURGERY

A 7-day limit on the initial opioid prescription may be sufficient for many common general surgery procedures, including hernia surgery and gynecologic procedures, findings of a large retrospective study suggest.

Duration of initial opioid prescription and first refill by procedure

Refill rates were the least at 11.3% for cholecystectomy and the most at 39.3% after anterior cruciate ligament repair. The time after the initial prescription until a refill was a median 6 days for appendectomy, cholecystectomy, and inguinal hernia repair, compared with a median 10 days for discectomy. The median duration of a refill prescription was 4 days for appendectomy, cholecystectomy, hernia repair, and hysterectomy versus 8 days for discectomy.

“Although 7 days appears to be more than adequate for many patients undergoing common general surgery and gynecologic procedures, prescription lengths likely should be extended to 10 days, particularly after common neurosurgical and musculoskeletal procedures, recognizing that as many as 40% of patients may still require one refill at a 7-day limit,” Dr. Scully and her associates said.

Although this study did not include rates of unused prescriptions or use of nonopioid pain relievers such as acetaminophen or NSAIDs, it did include a large population considered to be nationally representative “in many respects,” and it included a variety of procedures for which patients are commonly discharged to home, the researchers said.

The study was funded in part by the Department of Defense/Henry M. Jackson Foundation. The investigators had no conflict of interests. Adil H. Haider, MD, MPH, is deputy editor of JAMA Surgery, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance.

Recommended Reading

Acupuncture Flops as Relief for Muscle Pain From Aromatase Inhibitors
Breast Cancer ICYMI
Duloxetine Eases Pain of Chemo-Induced Neuropathy
Breast Cancer ICYMI
Vitamin D Eases Aromatase Inhibitor-Related Arthralgia
Breast Cancer ICYMI
FDA Approves REMS for Long-Acting Opioids
Breast Cancer ICYMI
Walking program eased chemo-related joint pain
Breast Cancer ICYMI
Exercise dampens aromatase inhibitor–related joint pain
Breast Cancer ICYMI
Topical lidocaine reduces menopausal dyspareunia
Breast Cancer ICYMI
Halogenated anesthetic linked to less chronic postop mastectomy pain
Breast Cancer ICYMI
Younger age, greater anxiety, affect pain after breast reconstruction
Breast Cancer ICYMI
New persistent opioid use common after cancer surgery
Breast Cancer ICYMI